Cargando…
The Pathogenic Role of Very Low Density Lipoprotein on Atrial Remodeling in the Metabolic Syndrome
Atrial fibrillation (AF) is the most common persistent arrhythmia, and can lead to systemic thromboembolism and heart failure. Aging and metabolic syndrome (MetS) are major risks for AF. One of the most important manifestations of MetS is dyslipidemia, but its correlation with AF is ambiguous in cli...
Autores principales: | Lee, Hsiang-Chun, Lin, Yi-Hsiung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037013/ https://www.ncbi.nlm.nih.gov/pubmed/32019138 http://dx.doi.org/10.3390/ijms21030891 |
Ejemplares similares
-
The role of postprandial very-low-density lipoprotein in the development of atrial remodeling in metabolic syndrome
por: Lee, Hsiang-Chun, et al.
Publicado: (2020) -
Very-Low-Density Lipoprotein of Metabolic Syndrome Modulates Gap Junctions and Slows Cardiac Conduction
por: Lee, Hsiang-Chun, et al.
Publicado: (2017) -
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
por: Huang, Jih-Kai, et al.
Publicado: (2022) -
Very Low-Density Lipoproteins of Metabolic Syndrome Modulates STIM1, Suppresses Store-Operated Calcium Entry, and Deranges Myofilament Proteins in Atrial Myocytes
por: Shiou, Yi-Lin, et al.
Publicado: (2019) -
Association of lipid composition and unsaturated fatty acids of VLDL with atrial remodeling in metabolic syndrome
por: Lee, Hsiang-Chun, et al.
Publicado: (2023)